Palatin Technologies Inc. (PTN)

[mike1986]

When it gets to 10 US we will be there. Right now it has not gotten to its pre-reverse split level.

[zeusgodmd]

Going mountain climbing on share price

[zeusgodmd]

Getting closer to a pop

[zeusgodmd]

Going to pop nice call below 2.50 last time it will be there

[zeusgodmd]

After reverse split shares tight and low will pop big when she is ready seams to have reversed last 2 days

[zeusgodmd]

At some point someone will buy us or team up to take it to the public. We are too close to the end here to not be looking or someone looking to buy us

[zeusgodmd]

I will take 50,60 or 70 company will be bought out buy a phizer or Merck give it time but this cheap will be taken out maybe wake up at 30$ buy out offer fine with me

[zeusgodmd]

Does not look like a stock going off into greatness but that’s where I usually mess up so in it to win it.

[zeusgodmd]

Doubled my bet today

[zeusgodmd]

No company will be bought before eye drops and ibs med approval that’s why analysts say she goes to 70$. I’m not a rocket scientist but at 2.60 that spread seems pretty good. I got time to wait it out.

[mike1986]

I don't know but PTN stock price is in the toilet. Is there a problem with the phase III clinical trial of the eye ointment?

[BesaoT35]

Do analyst stated price targets have any real meaning if the financial institution that employs the analyst does business with the company being analyzed? Thanks

[zeusgodmd]

Given 70 price up grade and going down good day to buy some so I did will be bought out with products getting closer to the end of research

[mike1986]

Every time this company says boo there is a sell off.

[BesaoT35]

Correction: The disease addressed in the presentation to gastroenterologists is Ulcerative Colitis and not Inflammatory Bowel Disease (IBD) as I stated. Perhaps though the two are related.

[BesaoT35]

PTN is up 20% in the past few days coinciding with the gastroenterology presentation. Any insight about what were the material pieces of data or whether there is a direct relationship to the IBD drug?

Thanks

[BesaoT35]

I hadn’t considered management getting paid to stifle Vyleesi as a possibility. That would be fraud against PTN shareholders. It wouldn’t take much money perhaps to pay off an executive compared to the billions in profits from Viagra, Cialis and other meds.

I took bremelanotide two years ago bought from the UK (for research only) and went to a high quality strip club and did notice an increased level of visual excitement, arousal and desire regarding the topless young dancing ladies. It seems to work remarkably well for me.

Transdermal patch technology could be an ideal route of administration. The next best thing would be a nasal spray or dropper. I do think that men is the true market for this drug. Men must achieve a long lasting hard erection. Women do not have that level of performance execution requirement.

The $1000 a month price tag is too high for the general public to access this valuable med. Perhaps other countries could take this drug and make it available at a reasonable price.

$20 to $30 per dose would be reasonable in my mind.

[Monroe1]

You are exactly right. Men should not be denied however the idea was to market to women...where there was not any competition, then of course husbands and boyfriends would use it too...even more than women. The lousy marketing efforts by the contracted sales company was so pitiful... i think on purpose. The company itself could have done a better job by employing a sales force. It is a no brainer sale....but the price was so high to make it effectively out of reach for the majority of people. This CEO is the poorest I have ever seen. First of all they basically stole the drug from Australia anyway.

It was marketed on the black market, you could buy it in England and other places. It works .... so well ..... it is actually a game changer for men especially.

I have never seen a better product stifled by mismanagement. I do believe the company is being paid... or has been paid to keep it off the market to any large degree. All the while the insiders rake in their salary too.

I fully expect if this continues to see the company go under or go private which will be what happens IMO either through a merger, buyout, or bankruptcy. Keeping erect for 80 minutes is more than a gold mine.

[zeusgodmd]

Earnings in one day let’s go. Will be before market opens

[Basil22]

I hope

[zeusgodmd]

My bet Pfizer buys them out soon for eye and gi pipeline

[zeusgodmd]

I think she goes to 12$

[zeusgodmd]

Ready to go parabolic

[zeusgodmd]

Ladenburg thalmann

[zeusgodmd]

They got another 50$ price target

[dfrank1988]

PHASE 2 CLINICAL STUDY EVALUATING ORAL PL8177

[zeusgodmd]

You can scroll the new button for ptn also on fidelity

[Basil22]

Have not see this.

[zeusgodmd]

I’m fine if they’re off by 10 dollars

[zeusgodmd]

HC Wainright

[mike1986]

Set by whom?

[zeusgodmd]

70$ price target set at noon

[BesaoT35]

The market cap is now reported as $39 million for PTN. It should be true to my knowledge that this is less than the cash held by PTN. I do not think there is debt. Please correct me if I am wrong about those things. Thanks.

[BesaoT35]

The market cap is $60 million. I think I saw recently that PTN has $60 million left from what AMAG gave to PTN to drop Vyleesi.

A valuation of a company at cash on hand should be some sort of floor fundamentally.

In the short term stocks are a popularity contest. Reverse stock splits are unpopular. In the long term stock valuation is a weighing process.

The DED treatment could actually work.

Vyleesi is FDA approved and works better in men than in women. Women are not a good market for an aphrodisiac but men would be a strong market.

It is hard I understand however to believe in a company that has never delivered for its shareholders in the past.

[BesaoT35]

Analysts had a price target of around $3.00. Does that target now get automatically updated to $75?

[zeusgodmd]

Looks like she’s going to pop soon

[BesaoT35]

Vyleesi aka PTN-141 aka bremelanotide is in fact an effective aphrodisiac. Somehow this fact just got buried. This is counterintuitive. The drug works, but the company failed to market the drug effectively.

The DED treatment uses a novel mechanism of action. It could be more effective than the SOC. Phase 3 with finish fairly soon.

Informing the shareholder is not a high priority with the PTN management. Vyleesi could get discovered by women and shared with husbands and other partners. Men benefit even more than do women on average. This never gets discussed. Why should men be denied?

[Tom turtles]

Sales increase 225% last quarter and the stock sits at a 5 year low. Fu cking scum sucking management....Give back to your shareholders for once.

[BesaoT35]

Is Vyleesi a product potentially delivered in a patch. Are there countries where men can use Vyleesi?

[BesaoT35]

Could it be the Dry Eye treatment that has sparked an interest here? There is also an IBD treatment in trials? Vyleesi also works in men which would be a large market. A Vyleesi patch if possible would avoid the needle that limits demand for this sort of nonessential product.

[The GidDy uP Kid]

PTN... .41 here after... aDDed... GidDy uP PTN...
https://schrts.co/xRXNXBFC

[The GidDy uP Kid]

PTN... GidDy uP PTN...

[The GidDy uP Kid]

PTN... .3980 here after hours... GidDy uP PTN...

[The GidDy uP Kid]

PTN… .38… Had unusual volume blocks the first 30 minutes this morning… Daily psar fliPPed to the bullish side yesterday, with the gap filling from December on Monday… GidDy uP PTN...
https://schrts.co/PnCIIKcd

[BesaoT35]

If Vyleesi could be a patch it would be a big seller.

[zeusgodmd]

Doing the upwardly crawl

[zeusgodmd]

You should see it soon. Good new coming from this company

[Tom turtles]

Sitting at .76......patiently waiting

[zeusgodmd]

Pfizer bought out arena for there ulcerative colitis med sock up 40$

[halbroke1]

PTN $$$ READY TO ROCK...LETS GO..FIRST $1.00+, THEN $5.00+..